MRM vs XPOF vs PLNT vs MNMD vs HIMS

For growth investors, Hims & Hers Health, Inc.

(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus -1. 7% for Xponential Fitness, Inc. (XPOF). MEDIROM Healthcare Technologies Inc. (MRM) offers the better valuation at 6. 4x trailing P/E, making it the more compelling value choice. Analysts rate Xponential Fitness, Inc. (XPOF) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, MEDIROM Healthcare Technologies Inc.

(MRM) is the cheapest at 6. 4x versus Hims & Hers Health, Inc. at 50. 3x. On forward P/E, Xponential Fitness, Inc. is actually cheaper at 10. 9x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Hims & Hers Health, Inc.

(HIMS) delivered a total return of +137. 6%, compared to -88. 2% for MEDIROM Healthcare Technologies Inc. (MRM). Over 10 years, the gap is even starker: MNMD returned +512. 1% versus MRM's -92. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), MEDIROM Healthcare Technologies Inc.

(MRM) is the lower-risk stock at -0. 54β versus Hims & Hers Health, Inc. 's 2. 40β — meaning HIMS is approximately -541% more volatile than MRM relative to the S&P 500. On balance sheet safety, Hims & Hers Health, Inc. (HIMS) carries a lower debt/equity ratio of 2% versus 3% for MEDIROM Healthcare Technologies Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Hims & Hers Health, Inc.

(HIMS) is pulling ahead at 59. 0% versus -1. 7% for Xponential Fitness, Inc. (XPOF). On earnings-per-share growth, the picture is similar: Xponential Fitness, Inc. grew EPS 35. 2% year-over-year, compared to -1273. 3% for Mind Medicine (MindMed) Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Planet Fitness, Inc.

(PLNT) is the more profitable company, earning 16. 5% net margin versus -10. 7% for Xponential Fitness, Inc. — meaning it keeps 16. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PLNT leads at 29. 8% versus -0. 2% for MRM. At the gross margin level — before operating expenses — PLNT leads at 82. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Xponential Fitness, Inc.

(XPOF) trades at 10. 9x forward P/E versus 51. 5x for Hims & Hers Health, Inc. — 40. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PLNT: 170. 8% to $119. 17.

In this comparison, XPOF (2.

5% yield) pays a dividend. MRM, PLNT, MNMD, HIMS do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, MEDIROM Healthcare Technologies Inc.

(MRM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 54)). Hims & Hers Health, Inc. (HIMS) carries a higher beta of 2. 40 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MRM: -92. 3%, HIMS: +161. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (MRM (Consumer Cyclical) and XPOF (Consumer Cyclical) and PLNT (Consumer Cyclical) and MNMD (Healthcare) and HIMS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MRM is a small-cap high-growth stock; XPOF is a small-cap quality compounder stock; PLNT is a small-cap deep-value stock; MNMD is a small-cap quality compounder stock; HIMS is a small-cap high-growth stock. XPOF pays a dividend while MRM, PLNT, MNMD, HIMS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.